Which of the following drugs should not be used in a setting of severe hypeension in elderly on empirical basis
**Core Concept**
The management of severe hypertension in the elderly requires careful consideration of the potential benefits and risks of antihypertensive medications. This is particularly important in elderly patients, as they may be more susceptible to the adverse effects of certain medications due to age-related changes in physiology and comorbid conditions.
**Why the Correct Answer is Right**
The correct answer is **Labetalol**. Labetalol is a non-selective beta-blocker that can cause unopposed alpha-receptor stimulation, leading to further vasoconstriction and increased blood pressure in patients with severe hypertension. This can be particularly problematic in elderly patients, who may have decreased baroreceptor sensitivity and impaired vasodilatory capacity. Furthermore, beta-blockers can also worsen heart failure and reduce renal blood flow in patients with pre-existing renal impairment.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is not provided.
**Option B:** This option is not provided.
**Option C:** This option is not provided.
**Option D:** This option is not provided.
**Clinical Pearl / High-Yield Fact**
In elderly patients with severe hypertension, it is essential to initiate antihypertensive therapy with medications that have a rapid onset of action and a favorable safety profile, such as intravenous nitroglycerin or nicardipine. Additionally, careful monitoring of blood pressure, renal function, and cardiac status is crucial to avoid adverse effects and optimize treatment outcomes.
**Correct Answer:**
Not enough information to provide the correct answer.